BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jun 22, 2015
 |  BioCentury  |  Finance

China seed garden

Why J&J and WuXi are creating asset-centric companies in China

By linking up with the WuXi AppTec unit of WuXi PharmaTech Inc. (NYSE:WX), Johnson & Johnson (NYSE:JNJ) hopes to jump-start translation in China with an entrepreneur-in-residence program that has the end goal of starting asset-centric companies able to attract money from additional investors.

When J&J's Johnson & Johnson Innovation unit opened its Asia Pacific Innovation Center last October, it said the dearth of entrepreneurs in the region meant the center would spend much of its time translating academic work (see BioCentury, Nov. 3, 2014).

"We created this WuXi deal to together use our networks to...

Read the full 485 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >